Publications Preclinical Evaluation of AT-527, a Novel Guanosine Nucleotide Prodrug with Potent, Pan-genotypic Activity Against Hepatitis C Virus Source Published in PLoS ONE. 2020. DOI: e0227104. Read More Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis Source Published in Antimicrobial Agents & Chemotherapy. 2019. Volume 63, Issue 12. DOI: 10.1128/AAC.01201-19. Read More Pagination First page « first Previous page ‹ previous Page 1 Current page 2
Preclinical Evaluation of AT-527, a Novel Guanosine Nucleotide Prodrug with Potent, Pan-genotypic Activity Against Hepatitis C Virus Source Published in PLoS ONE. 2020. DOI: e0227104. Read More
Safety, Pharmacokinetics, and Antiviral Activity of AT-527, a Novel Purine Nucleotide Prodrug, in Hepatitis C Virus-Infected Subjects with or without Cirrhosis Source Published in Antimicrobial Agents & Chemotherapy. 2019. Volume 63, Issue 12. DOI: 10.1128/AAC.01201-19. Read More